Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16942552 | 0.95 | L3MBTL1 (0.55) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL20576630 | 0.95 | L3MBTL1 (0.55) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL29784894 | 0.95 | L3MBTL1 (0.55) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL14733290 | 0.90 | MEN1 (0.53) | L3MBTL1TSHRLMNAPPARGKMT2A | |
| SCHEMBL28709667 | 0.88 | TSHR (0.58) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL17690438 | 0.84 | MEN1 (0.57) | L3MBTL1TSHRLMNAPPARGKMT2A | |
| SCHEMBL15964153 | 0.84 | MEN1 (0.57) | L3MBTL1TSHRLMNAPPARGKMT2A | |
| SCHEMBL1985687 | 0.84 | MEN1 (0.57) | L3MBTL1TSHRLMNAPPARGKMT2A | |
| SCHEMBL16867576 | 0.84 | MEN1 (0.57) | L3MBTL1TSHRLMNAPPARGKMT2A | |
| SCHEMBL14733287 | 0.84 | MEN1 (0.57) | L3MBTL1TSHRLMNAPPARGKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8835663-B2 | Lubricity improver | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2014-09-16 | — | — | US | disclosed |
| US-8835663-B2 | Lubricity improver | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2014-09-16 | — | — | US | disclosed |
| US-20130053590-A1 | LUBRICITY IMPROVER | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130053590-A1 | LUBRICITY IMPROVER | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053590-A1 | LUBRICITY IMPROVER | ELOVL1, ELOVL5, FASN | L3MBTL1 3484/4885TSHR 4404/4885LMNA 3849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.